| Literature DB >> 26363366 |
Shweta Jain1, Jing Chen2, Alina Nicolae3, Hongsheng Wang1, Dong-Mi Shin4, Elisabeth B Adkins5, Thomas J Sproule6, Caroline M Leeth7, Tomomi Sakai1, Alexander L Kovalchuk1, Mark Raffeld3, Jerrold M Ward1, Jerold E Rehg8, Thomas A Waldmann2, Elaine S Jaffe3, Derry C Roopenian5, Herbert C Morse9.
Abstract
SJL/J mice exhibit a high incidence of mature B-cell lymphomas that require CD4(+) T cells for their development. We found that their spleens and lymph nodes contained increased numbers of germinal centers and T follicular helper (TFH) cells. Microarray analyses revealed high levels of transcripts encoding IL-21 associated with high levels of serum IL-21. We developed IL-21 receptor (IL21R)-deficient Swiss Jim Lambart (SJL) mice to determine the role of IL-21 in disease. These mice had reduced numbers of TFH cells, lower serum levels of IL-21, and few germinal center B cells, and they did not develop B-cell tumors, suggesting IL-21-dependent B-cell lymphomagenesis. We also noted a series of features common to SJL disease and human angioimmunoblastic T-cell lymphoma (AITL), a malignancy of TFH cells. Gene expression analyses of AITL showed that essentially all cases expressed elevated levels of transcripts for IL21, IL21R, and a series of genes associated with TFH cell development and function. These results identify a mouse model with features of AITL and suggest that patients with the disease might benefit from therapeutic interventions that interrupt IL-21 signaling.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26363366 PMCID: PMC4630166 DOI: 10.1016/j.ajpath.2015.07.021
Source DB: PubMed Journal: Am J Pathol ISSN: 0002-9440 Impact factor: 4.307